Eye Reports. 2011;1(1):-. doi: 10.4081/eye.2011.e5 N/A0.02025
What are the half-lives of ranibizumab and aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical model
DOI: 10.4081/eye.2011.e5
摘要 查看摘要
Eye Reports. 2011;1(1):-. doi: 10.4081/eye.2011.e5 N/A0.02025
DOI: 10.4081/eye.2011.e5
摘要 查看摘要